SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
60 hedge funds and large institutions have $76.5M invested in Sierra Oncology, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
60
Holding in Top 10
1
Calls
$34K
Puts
–
Top Buyers
| 1 | +$3.37M | |
| 2 | +$1.55M | |
| 3 | +$932K | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$828K |
| 5 |
Renaissance Technologies
New York
|
+$825K |
Top Sellers
| 1 | -$5.22M | |
| 2 | -$3.04M | |
| 3 | -$2.37M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.21M |
| 5 |
Millennium Management
New York
|
-$1.41M |